GSK Looks To Identify Novel Interventions In Parkinson’s With Vesalius

 
• By Joseph Haas

Deal Snapshot: Flagship-backed Vesalius will use its AI/machine learning platform to seek novel intervention points and underlying causes to better address Parkinson’s disease in GSK alliance.

GSK will team with Vesalius to seek novel intervention points in Parkinson's (Shutterstock)

More from Deals

More from Digital Technologies